Effect of smoking cessation on mortality after myocardial infarction: Meta-analysis of cohort studies

Archives of Internal Medicine

Volumn 160, Issue 7, 2000, Pages 939-944

  Wilson, Kumanan ^a,b   Gibson, Neil ^a   Willan, Andrew ^a   Cook, Deborah ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Civic Parkdale Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING CESSATION;

EID: 0034630424     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.7.939     Document Type: Article

References (45)

1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll RI. Mortality from smoking worldwide. Br Med Bull. 1996;52:12-21.
2. Cryer PE, Haymond MW. Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295:573-577.
3. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez JAG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol. 1993;22:642-647.
4. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and the risk of cardiovascular disease: insights from the Framingham Study. Am Heart J. 1987;113:1006-1010.
5. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987;2:986-988.
6. Schmidt KG, Rasmussen JW. Acute platelet activation induced by smoking: in vivo and ex vivo studies in humans. Thromb Haemost. 1984;51:279-282.
7. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993:22:1159-1167.
8. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: results from the CASS registry. N Engl J Med. 1988;319:1365-1369.
9. Taylor CB, Houston-Miller N, Killen JD, DeBusk RF. Smoking cessation after myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med. 1990; 113:118-123.
10. Taylor CB, Houston-Miller N, Haskell WL, Debusk RF. Smoking cessation after acute myocardial infarction: the effects of exercise training. Addict Behav. 1988; 13:331-335.
11. Rigotti N, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery: results of a randomized trial with 5-year followup. Ann Intern Med. 1994;120:287-293.
12. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996; 335:1792-1798.
13. Mulcahy R, Hickey N, Graham IM, MacAirt J. Factors affecting the 5 year survival rate of men following acute coronary heart disease. Am Heart J. 1977;93: 556-559.
14. Sparrow D, Dawber TR, Colton T. The influence of cigarette smoking on prognosis after a first myocardial infarction: a report from the Framingham Study. J Chronic Dis. 1978;31:425-432.
15. Salonen JT. Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J. 1980;43:463-469.
16. Rodda BE. The Timolol Myocardial Infarction Study: an evaluation of selected variables. Circulation. 1983;67(suppl 1):1101-1106.
17. Aberg A, Bergstrand R, Johansson S, et al. Cessation of smoking after myocardial infarction: effects on mortality after 10 years. Br Heart J. 1983;49:416-422.
18. Perkins J, Dick TB. Smoking and myocardial infarction: secondary prevention. Postgrad Med J. 1985;61:295-300.
19. Johansson S, Bergstrand R, Pennert K, et al. Cessation of smoking after myocardial infarction in women: effects on mortality and reinfarctions. Am J Epidemiol. 1985;121:823-831.
20. Burr ML, Holliday RM, Fehily AM, Whitehead PJ. Haematological prognostic indices after myocardial infarction: evidence from the Diet and Reinfarction Trial (DART). Eur Heart J. 1992;13:166-170.
21. Hedback B, Perk J, Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur Heart J. 1993;14:831-835.
22. Tofler GH, Muller JE, Stone PH, Davies G, Davis VG, Braunwald E. Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Am J Cardiol. 1993; 71:1031-1035.
23. Herlitz J, Bengston A, Hjalmarson A, Karlson BW. Smoking habits in consecutive patients with acute myocardial infarction: prognosis in relation to other risk indicators and to whether or not they quit smoking. Cardiology. 1995;86:496-502.
24. Greenwood DC, Muir KR, Packham CJ, Madeley RJ. Stress, social support, and stopping smoking after myocardial infarction in England. J Epidemiol Community Health. 1995;49:583-587.
25. Mulcahy R, Hickey N, Graham I, McKenzie G. Factors influencing long-term prognosis in male patients surviving first coronary attack. Br Heart J. 1975;37:158-165.
26. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L. Smoking and myocardial infarction. Lancet. 1975;1:410-415.
27. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994;1:447-458.
28. Raudenbush SW. Random effects models. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994.
29. Ronnevik PK, Gundersen T, Abrahamsen AM. Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction. Br Heart J. 1985;54:134-139.
30. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
31. Sackett DL, Deeks JJ, Altman DG. Down with odds ratios [editorial]. Evidence-Based Med. 1996;1:164-166.
32. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med. 1997;126:712-720.
33. Voors AA, Van Brussel BL, Plokker T, et al. Smoking and cardiac events after venous coronary bypass surgery. Circulation. 1996;93:42-47.
34. Hasdai D, Garrat KN, Grill DE, Lerman A, Holmes DR Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336:755-761.
35. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-254.
36. Chalmers TC, Celano P, Sacks HS, Smith H Jr. Bias in treatment assignment in controlled clinical trials. N Engl J Med. 1983;309:1358-1361.
37. Miller JN, Colditz GA. How study design affects outcomes in comparisons of therapy, II: surgical. Stat Med. 1989;8:455-466.
38. Wilcox RG, Hughes J, Roland J. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. BMJ. 1979;2:1026-1028.
39. Perkins KA. Maintaining smoking abstinence after myocardial infarction. J Subst Abuse. 1988;1:91-107.
40. Pohjola S, Siltanen P, Roma M, Haapakoski J. Effect of quitting smoking on the long-term survival after myocardial infarction. Trans Eur Soc Cardiol. 1979;1:2. Abstract 33.
41. Goldberg R, Szklo M, Chandra V. The effect of cigarette smoking on the long-term prognosis of myocardial infarction [abstract]. Am J Epidemiol. 1981;114: 431.
42. Julian JA. Summary Odds Ratios for 2X2Xk Tables (Version 1.0) [software]. Hamilton, Ontario: McMaster University.
43. Burling TA, Singleton EG, Bigelow GE, Baile WF, Gottlieb SH. Smoking following myocardial infarction: a critical review of the literature. Health Psychol. 1984;3: 83-96.
44. Rigotti NA, Singer DE, Mulley AG, Thibault GE. Smoking cessation following admission to a coronary care unit. J Gen Intern Med. 1991;6:305-311.
45. Working group for the study of transdermal nicotine in patients with coronary artery disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med. 1994;154:989-995.